Notice of Change to Application Due Date for PAR-24-062, "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)"
Notice Number:
NOT-DA-24-026

Key Dates

Release Date:

April 17, 2024

Related Announcements

November 08, 2023 - Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional).  See NOFO PAR-24-062

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the updates for PAR-24-062, "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)".

The following sections of PAR-24-062 have been updated to reflect the new dates:

Part 1. Overview Information

Key Dates
 

Currently reads:

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS - New/Renewal/Resubmission/Revision, as allowed

Scientific Merit Review

Advisory Council Review

Earliest Start Date

February 14, 2024Not ApplicableMarch 15, 2024July 2024October 2024December 2024
August 14, 2024August 14, 2024August 14, 2024November 2024January 2025April 2025
November 13, 2024November 13, 2024December 13, 2024March 2025May 2025July 2025
February 14, 2025February 14, 2025March 17, 2025July 2025October 2025December 2025
August 14, 2025August 14, 2025August 14, 2025November 2025January 2026April 2026
November 14, 2025November 14, 2025December 15, 2025March 2026May 2026July 2026
February 13, 2026February 13, 2026March 16, 2026July 2026October 2026December 2026
August 14, 2026August 14, 2026August 14, 2026November 2026January 2027April 2027
November 13, 2026November 13, 2026December 14, 2026March 2027May 2027July 2027

Modified to Read: (changes in bold Italic)

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS - New/Renewal/Resubmission/Revision, as allowed

Scientific Merit Review

Advisory Council Review

Earliest Start Date

February 14, 2024Not ApplicableMarch 15, 2024July 2024October 2024December 2024
June 14, 2024June 14, 2024August 14, 2024November 2024January 2025April 2025
October 11, 2024October 11, 2024December 13, 2024March 2025May 2025July 2025
February 14, 2025February 14, 2025March 17, 2025July 2025October 2025December 2025
June 13, 2025June 13, 2025August 14, 2025November 2025January 2026April 2026
October 10, 2025October 10, 2025December 15, 2025March 2026May 2026July 2026
February 13, 2026February 13, 2026March 16, 2026July 2026October 2026December 2026
June 15, 2026, 2026June 15, 2026August 14, 2026November 2026January 2027April 2027
October 14, 2026October 14, 2026December 14, 2026March 2027May 2027July 2027

    All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Amy B. Goldstein, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-827-4124
Email: amy.goldstein@nih.gov 

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®